ArticleInternational journal of cancer2025

Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune-related adverse events during treatment with immune checkpoint inhibitors.

Christina Schmitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.